⌘K

Login Start Free

Home/Filings/4/0001724521-25-000015

4//SEC Filing

Lacey David L. 4

Accession 0001724521-25-000015

CIK 0001724521other

View on SEC.gov Company Profile

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:30 PM ET

Size

5.8 KB

Accession

0001724521-25-000015

Insider Transaction Report

Form 4

Period: 2025-01-23

Arcus Biosciences, Inc.RCUS

Director

Transactions

Award
Stock Option (right to buy)
2025-01-23+5,000→ 5,000 total
Exercise: $13.33Exp: 2035-01-22→ Common Stock (5,000 underlying)

Holdings

Common Stock
57,652

Footnotes (1)

[F1]The option is exercisable in 24 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.

Documents

1 file

4
wk-form4_1738013395.xmlPrimary
FORM 4

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1

filerCIK 0001734422

Filing Metadata

Form type: 4
Filed: Jan 26, 7:00 PM ET
Accepted: Jan 27, 4:30 PM ET
Size: 5.8 KB

View on SEC.gov